231 related articles for article (PubMed ID: 8676222)
41. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
[TBL] [Abstract][Full Text] [Related]
42. Cutaneous infiltration by leukemic cells in acute promyelocytic leukemia of a child after treatment with all-trans retinoic acid.
Kishimoto S; Ishii E; Murakami Y; Takeshita M; Watanabe M; Sakai R; Miyazaki S
Pediatr Hematol Oncol; 1997; 14(2):169-75. PubMed ID: 9089745
[TBL] [Abstract][Full Text] [Related]
43. Unlocking the potential of retinoic acid in anticancer therapy.
Schenk T; Stengel S; Zelent A
Br J Cancer; 2014 Nov; 111(11):2039-45. PubMed ID: 25412233
[TBL] [Abstract][Full Text] [Related]
44. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
[TBL] [Abstract][Full Text] [Related]
45. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
[TBL] [Abstract][Full Text] [Related]
46. All-trans retinoic acid (ATRA) therapeutical effect in acute promyelocytic leukemia.
Degos L
Biomed Pharmacother; 1992; 46(5-7):201-9. PubMed ID: 1467448
[TBL] [Abstract][Full Text] [Related]
47. ATRA(ouble) in the treatment of acute promyelocytic leukemia.
Ozpolat B; Lopez-Berestein G; Mehta K
J Biol Regul Homeost Agents; 2001; 15(2):107-22. PubMed ID: 11501968
[TBL] [Abstract][Full Text] [Related]
48. Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group.
Fenaux P; Chastang C; Degos L
Leukemia; 1994; 8 Suppl 2():S42-7. PubMed ID: 7815836
[TBL] [Abstract][Full Text] [Related]
49. All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis.
Ma Y; Liu L; Jin J; Lou Y
PLoS One; 2016; 11(7):e0158760. PubMed ID: 27391027
[TBL] [Abstract][Full Text] [Related]
50. Effect of dialysis on all trans retinoic acid levels in a child with acute promyelocytic leukemia and renal failure.
Rajpurkar M; Alcasabas P; Warrier I; Valentini RP; Fassinger N; Frattarelli DA; Ravindranath Y
Pediatr Blood Cancer; 2007 Dec; 49(7):994-6. PubMed ID: 16609947
[TBL] [Abstract][Full Text] [Related]
51. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].
Xu SN; Chen JP; Liu JP; Xia Y
Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733
[TBL] [Abstract][Full Text] [Related]
52. Administration of granulocyte colony-stimulating factor during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia.
Usuki K; Nishizawa Y; Endo M; Osawa M; Kitazume K; Iki S; Watanabe M; Urabe A
Int J Hematol; 1996 Oct; 64(3-4):213-9. PubMed ID: 8923783
[TBL] [Abstract][Full Text] [Related]
53. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
Cheng Y; Zhang L; Wu J; Lu A; Wang B; Liu G
Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687
[TBL] [Abstract][Full Text] [Related]
54. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
[TBL] [Abstract][Full Text] [Related]
55. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
Tallman MS
Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
[TBL] [Abstract][Full Text] [Related]
56. All- trans-retinoic acid-induced erythema nodosum in patients with acute promyelocytic leukemia.
Kuo MC; Dunn P; Wu JH; Shih LY
Ann Hematol; 2004 Jun; 83(6):376-80. PubMed ID: 14648024
[TBL] [Abstract][Full Text] [Related]
57. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
[TBL] [Abstract][Full Text] [Related]
58. [Scrotum exfoliative dermatitis with ulcers associated with treatment of acute promyelocytic leukemia with all-trans retinoic acid].
Tajima K; Sagae M; Yahagi A; Akiba J; Suzuki K; Hayashi T; Satoh S
Rinsho Ketsueki; 1998 Jan; 39(1):48-52. PubMed ID: 9492553
[TBL] [Abstract][Full Text] [Related]
59. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
Muindi JR; Frankel SR; Huselton C; DeGrazia F; Garland WA; Young CW; Warrell RP
Cancer Res; 1992 Apr; 52(8):2138-42. PubMed ID: 1559217
[TBL] [Abstract][Full Text] [Related]
60. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
